Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
Advances in Therapy - United States
doi 10.1007/s12325-020-01276-3
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2020
Authors
Publisher
Springer Science and Business Media LLC